Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power.
Poos AM, Schroeder C, Jaishankar N, Röll D, Oswald M, Meiners J, Braun DM, Knotz C, Frank L, Gunkel M, Spilger R, Wollmann T, Polonski A, Makrypidi-Fraune G, Fraune C, Graefen M, Chung I, Stenzel A, Erfle H, Rohr K, Baniahmad A, Sauter G, Rippe K, Simon R, Koenig R. Poos AM, et al. Among authors: makrypidi fraune g. Cancers (Basel). 2022 Mar 1;14(5):1267. doi: 10.3390/cancers14051267. Cancers (Basel). 2022. PMID: 35267575 Free PMC article.
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.
Kind S, Kluth M, Hube-Magg C, Möller K, Makrypidi-Fraune G, Lutz F, Lennartz M, Rico SD, Schlomm T, Heinzer H, Höflmayer D, Weidemann S, Uhlig R, Huland H, Graefen M, Bernreuther C, Tsourlakis MC, Minner S, Dum D, Hinsch A, Lübke AM, Simon R, Sauter G, Marx A, Polonski A. Kind S, et al. Among authors: makrypidi fraune g. Biomed Res Int. 2020 Oct 28;2020:5845374. doi: 10.1155/2020/5845374. eCollection 2020. Biomed Res Int. 2020. PMID: 33195694 Free PMC article.
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy.
Schroeder C, Navid-Hill E, Meiners J, Hube-Magg C, Kluth M, Makrypidi-Fraune G, Simon R, Büscheck F, Luebke AM, Goebel C, Lang DS, Weidemann S, Neubauer E, Hinsch A, Jacobsen F, Lebok P, Michl U, Pehrke D, Huland H, Graefen M, Schlomm T, Sauter G, Höflmayer D. Schroeder C, et al. Oncotarget. 2019 Aug 13;10(48):4973-4986. doi: 10.18632/oncotarget.27132. eCollection 2019 Aug 13. Oncotarget. 2019. PMID: 31452838 Free PMC article.
High homogeneity of mismatch repair deficiency in advanced prostate cancer.
Fraune C, Simon R, Höflmayer D, Möller K, Dum D, Büscheck F, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Hinsch A, Burandt E, Clauditz TS, Wilczak W, Sauter G, Steurer S. Fraune C, et al. Virchows Arch. 2020 May;476(5):745-752. doi: 10.1007/s00428-019-02701-x. Epub 2019 Dec 6. Virchows Arch. 2020. PMID: 31811435
High B7-H3 expression is linked to increased risk of prostate cancer progression.
Bonk S, Tasdelen P, Kluth M, Hube-Magg C, Makrypidi-Fraune G, Möller K, Höflmayer D, Dwertmann Rico S, Büscheck F, Minner S, Heinzer H, Graefen M, Hinsch A, Luebke AM, Dum D, Uhlig R, Schlomm T, Sauter G, Simon R, Weidemann SA. Bonk S, et al. Among authors: makrypidi fraune g. Pathol Int. 2020 Oct;70(10):733-742. doi: 10.1111/pin.12999. Epub 2020 Aug 10. Pathol Int. 2020. PMID: 32776718
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
Freytag M, Kluth M, Bady E, Hube-Magg C, Makrypidi-Fraune G, Heinzer H, Höflmayer D, Weidemann S, Uhlig R, Huland H, Graefen M, Bernreuther C, Wittmer C, Tsourlakis MC, Minner S, Dum D, Hinsch A, Luebke AM, Simon R, Sauter G, Schlomm T, Möller K. Freytag M, et al. Among authors: makrypidi fraune g. BMC Cancer. 2020 Dec 18;20(1):1220. doi: 10.1186/s12885-020-07682-8. BMC Cancer. 2020. PMID: 33339518 Free PMC article.
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer.
Bonk S, Kluth M, Jansen K, Hube-Magg C, Makrypidi-Fraune G, Höflmayer D, Weidemann S, Möller K, Uhlig R, Büscheck F, Luebke AM, Burandt E, Clauditz TS, Steurer S, Schlomm T, Huland H, Heinzer H, Sauter G, Simon R, Dum D. Bonk S, et al. Among authors: makrypidi fraune g. Prostate. 2020 Sep;80(13):1097-1107. doi: 10.1002/pros.24038. Epub 2020 Jul 6. Prostate. 2020. PMID: 32628300
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass.
Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kähler C, Kluth M, Höflmayer D, Büscheck F, Dum D, Luebke AM, Burandt E, Clauditz TS, Wilczak W, Sauter G, Steurer S. Fraune C, et al. Among authors: makrypidi fraune g. Urol Oncol. 2020 May;38(5):488-495. doi: 10.1016/j.urolonc.2019.12.012. Epub 2020 Feb 14. Urol Oncol. 2020. PMID: 32067846
Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers.
Möller K, Wecker AL, Höflmayer D, Fraune C, Makrypidi-Fraune G, Hube-Magg C, Kluth M, Steurer S, Clauditz TS, Wilczak W, Simon R, Sauter G, Huland H, Heinzer H, Haese A, Schlomm T, Weidemann S, Luebke AM, Minner S, Bernreuther C, Bonk S, Marx A. Möller K, et al. Among authors: makrypidi fraune g. Virchows Arch. 2020 Nov;477(5):625-636. doi: 10.1007/s00428-020-02834-4. Epub 2020 May 16. Virchows Arch. 2020. PMID: 32417965 Free PMC article.
High homogeneity of MMR deficiency in ovarian cancer.
Fraune C, Rosebrock J, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Höflmayer D, Schmalfeldt B, Müller V, Wölber L, Witzel I, Paluchowski P, Wilke C, Heilenkötter U, von Leffern I, Clauditz TS, Wilczak W, Sauter G, Steurer S, Burandt E. Fraune C, et al. Gynecol Oncol. 2020 Mar;156(3):669-675. doi: 10.1016/j.ygyno.2019.12.031. Epub 2020 Jan 8. Gynecol Oncol. 2020. PMID: 31924330
18 results